
Psoriasis Program in Pharmaceutical Benefits Scheme (PBS) 012-18051130

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

Psoriasis (PSOR) restriction and item codes

Do not share this attachment externally. See - Freedom of Information –
Information Publication Scheme.
[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
Psoriasis (PSOR) restriction and item codes

Calculator

Next assessment date calculator

Contact details

PBS Complex Drugs Programs team

Forms

Severe chronic plaque psoriasis – initial authority application (PB112)

Severe chronic plaque psoriasis – risankizumab – initial grandfather
authority application (PB266)

Severe chronic plaque psoriasis – etanercept – for patients under 18
years initial, re-treatment, course completion, change or recommencing
authority application (PB116)

Severe chronic plaque psoriasis – ustekinumab – for patients under 18
years initial, change, recommencement or demonstration of response
authority application (PB320)

Severe chronic plaque psoriasis – ustekinumab – for patients under 18
years continuing authority application (PB319)

Severe chronic plaque psoriasis – change, recommencement or
demonstration of response authority application (PB263)

Severe chronic plaque psoriasis – continuing authority application
(PB113)

Services Australia website

Psoriasis - severe chronic plaque psoriasis

External websites

PBS schedule for psoriasis (PSOR)

                                   

-   Services Australia ABN 90 794 605 008 
